Cancer Research Institute, Inc.
June 15, 2011
When I began my career in cancer research in 1989, CRI was the only organization that believed in supporting junior researchers as the future of cancer immunotherapy. I had just had my NIH grant turned down and CRI gave me an investigators grant that allowed me to launch my career. They then funded a number of postdoctoral fellows, who are now themselves independent cancer immunology leaders at institutions all over the world. Without CRI, I would not be doing this today. Starting in 2010, cancer immunotherapy has emerged as the "new" breakthrough approach to cancer therapy but this is actually the fruit of decades of labor and CRI has been steadfastly behind that research from the beginning.
I've personally experienced the results of this organization in...
funding my research and the research of postdoctoral scientists under my mentorship
Ways to make it better...
If I had to make changes to this organization, I would...
triple their funding so that their profound influence on cancer immunotherapy could be even further amplified
Professional with expertise in this field & I lead the team that developed a genetically modified cancer vaccine and an antibody, called anti-PD-1, that induces immune based cancer regressions in over half of patients with melanoma, kidney cancer and lung cancer.